Trastuzumab Deruxtecan in Non-Small-Cell Lung Cancer

N Engl J Med. 2022 May 5;386(18):1770. doi: 10.1056/NEJMc2202305.

Authors

Michael C Tjong¹, Raymond H Mak², Alexander V Louie³

Affiliations

¹ Sunnybrook Health Sciences Centre, Toronto, ON, Canada.
² Brigham and Women's Hospital, Boston, MA.
³ Sunnybrook Health Sciences Centre, Toronto, ON, Canada alexander.louie@sunnybrook.ca.

PMID: 35507495
DOI: 10.1056/NEJMc2202305

No abstract available

Publication types

Letter
Comment

MeSH terms

Camptothecin / analogs & derivatives
Carcinoma, Non-Small-Cell Lung* / drug therapy
Humans
Immunoconjugates*
Lung Neoplasms* / drug therapy
Trastuzumab / therapeutic use

Substances

Immunoconjugates
trastuzumab deruxtecan
Trastuzumab
Camptothecin